
Found 3 results
Filters: Author is Scholl, C [Clear All Filters]
Search Results
- Showing 1-3 of 3 Results
STK33 kinase inhibitor BRD-8899 has no effect on KRAS-dependent cancer cell viability. Proceedings of the National Academy of Sciences of the United States of America, 2012/02/21, Volume 109, Issue 8, p.2860-5, (2012)
Read More / View Supplemental Materials
Abstract
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature, 2009/11/05, Volume 462, Issue 7269, p.108-12, (2009)
Read More / View Supplemental Materials
Abstract
Identification of driver and passenger mutations of FLT3 by high-throughput DNA sequence analysis and functional assessment of candidate alleles. Cancer cell, 2007/12/01, Volume 12, Issue 6, p.501-13, (2007)
Read More / View Supplemental Materials
Abstract
- Showing 1-3 of 3 Results




